iBio has until May 18, 2027 to meet Nasdaq’s $1 bid rule
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
iBio, Inc. received notice from Nasdaq that its common stock did not maintain the $1.00 minimum closing bid price for 30 consecutive business days, from October 8 through November 18, 2026. The notice has no immediate effect on listing or trading; the stock continues to trade on The Nasdaq Capital Market under IBIO.
iBio has until May 18, 2027, the end of a 180-calendar-day compliance period, to regain compliance. The closing bid must be at least $1.00 for 10 consecutive business days during that period, although Nasdaq may require more. If iBio does not meet the requirement, it may qualify for another 180 days if it meets other listing standards and gives written notice of its intent to cure by effecting a reverse stock split, if necessary. iBio says it will monitor the bid price and consider options, including a reverse stock split.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- None.
Negative
- Moderate pointNasdaq bid-price deficiency: 30 consecutive business days below $1.00
Filing Explained
The reverse split iBio says it may use if needed is not a decided action; if implemented, it would reduce the share count and proportionally raise the per-share price, while the split itself would not change the company’s value.
8-K Event Classification
Key Figures
Key Terms
Minimum Bid Price Requirement regulatory
Nasdaq Listing Rule 5550(a)(2) regulatory
continued listing requirement regulatory
reverse stock split technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What happened to IBIO’s Nasdaq listing?
How can IBIO regain Nasdaq’s minimum bid-price compliance?
Can IBIO get more time to meet Nasdaq’s bid-price rule?
AI-generated analysis. How Rhea-AI works. Not financial advice.